0001315406-15-000014.txt : 20150814 0001315406-15-000014.hdr.sgml : 20150814 20150814170314 ACCESSION NUMBER: 0001315406-15-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150813 FILED AS OF DATE: 20150814 DATE AS OF CHANGE: 20150814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO RAD LABORATORIES INC CENTRAL INDEX KEY: 0000012208 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 941381833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 ALFRED NOBEL DR CITY: HERCULES STATE: CA ZIP: 94547 BUSINESS PHONE: 5107247000 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DR CITY: HERCULES STATE: CA ZIP: 94547 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOETZ JOHN CENTRAL INDEX KEY: 0001237945 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07928 FILM NUMBER: 151056907 MAIL ADDRESS: STREET 1: BIO-RAD LABORATIORIES STREET 2: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-13 0000012208 BIO RAD LABORATORIES INC BIO, BIOB 0001237945 GOETZ JOHN C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES CA 94547 0 1 0 0 EVP, Chief Operating Officer Bio-Rad A Common Stock 2015-08-13 4 M 0 7000 62.47 A 57965.5476 D Bio-Rad A Common Stock 2015-08-13 4 S 0 1999 146.75 D 55966.5476 D Bio-Rad A Common Stock 2015-08-13 4 S 0 2559 147.57 D 53407.5476 D Non-Qualified Stock Option (right to buy) 62.47 2015-08-13 4 M 0 7000 0 D 2016-04-03 Bio-Rad A Common Stock 7000 0 D Includes 31.2067, 58.6524 and 60.3804 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/14, 3/31/15 and 6/30/15, respectively. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.21 to $147.19 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.35 to $147.75 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vested in five equal annual installments beginning on April 3, 2007. John Goetz 2015-08-14